ALKERMES | Kortsiktig Gjeld

Current Liabilities Endring Dato
AbbVie USD 41.52B 6.75B 2024-03
Amgen USD 19.71B 1.32B 2024-03
Biogen USD 3.22B 211.5M 2024-03
BioMarin Pharmaceutical USD 1.09B 89.12M 2024-03
Bristol-Myers Squibb USD 25.82B 2.36B 2024-03
Eli Lilly USD 18.6B 3.4B 2024-03
Gilead Sciences USD 13.02B 1.74B 2024-03
Intra Cellular Therapies USD 134.8M 11.26M 2024-03
Ionis Pharmaceuticals USD 327.65M 120.44M 2024-03
J&J USD 48.72B 4.36B 2024-03
Malin Corporation EUR 1.3M 700K 2023-06
Merck USD 25.1B 2.01B 2024-03
Pfizer USD 40.5B 9.36B 2024-03
Regeneron Pharmaceuticals USD 3.58B 823.3M 2024-03
Vertex Pharmaceuticals USD 3.8B 196.5M 2024-03



ALKERMES Kortsiktig Gjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.